Logo image of BRDS

BIRD GLOBAL INC-CLASS A (BRDS) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:BRDS - US09077J2069 - Common Stock

0.9 USD
-0.01 (-1.52%)
Last: 9/22/2023, 8:04:01 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BRDS. BRDS was compared to 43 industry peers in the Ground Transportation industry. Both the profitability and financial health of BRDS have multiple concerns. BRDS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BRDS has reported negative net income.
In the past year BRDS has reported a negative cash flow from operations.
BRDS Yearly Net Income VS EBIT VS OCF VS FCFBRDS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -100M -200M -300M

1.2 Ratios

The profitability ratios for BRDS are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BRDS Yearly ROA, ROE, ROICBRDS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 -500 -1K

1.3 Margins

BRDS's Gross Margin of 37.01% is in line compared to the rest of the industry. BRDS outperforms 43.59% of its industry peers.
The Profit Margin and Operating Margin are not available for BRDS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BRDS Yearly Profit, Operating, Gross MarginsBRDS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 -50 -100 -150 -200 -250

More info and screens

0

2. Health

2.1 Basic Checks

BRDS does not have a ROIC to compare to the WACC, probably because it is not profitable.
BRDS has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, BRDS has a worse debt to assets ratio.
BRDS Yearly Shares OutstandingBRDS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 50M 100M 150M 200M 250M
BRDS Yearly Total Debt VS Total AssetsBRDS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of -12.27, we must say that BRDS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -12.27, BRDS is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -12.27
ROIC/WACCN/A
WACC9.84%
BRDS Yearly LT Debt VS Equity VS FCFBRDS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 200M -200M

2.3 Liquidity

BRDS has a Current Ratio of 0.21. This is a bad value and indicates that BRDS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.21, BRDS is not doing good in the industry: 87.18% of the companies in the same industry are doing better.
BRDS has a Quick Ratio of 0.21. This is a bad value and indicates that BRDS is not financially healthy enough and could expect problems in meeting its short term obligations.
BRDS has a worse Quick ratio (0.19) than 87.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.19
BRDS Yearly Current Assets VS Current LiabilitesBRDS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for BRDS have decreased strongly by -441.18% in the last year.
BRDS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.19%.
Measured over the past years, BRDS shows a quite strong growth in Revenue. The Revenue has been growing by 17.58% on average per year.
EPS 1Y (TTM)-441.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-108.57%
Revenue 1Y (TTM)-11.19%
Revenue growth 3Y17.58%
Revenue growth 5YN/A
Sales Q2Q%-52.68%

3.2 Future

BRDS is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -20.92% yearly.
The Revenue is expected to grow by 9.96% on average over the next years. This is quite good.
EPS Next Y-52.06%
EPS Next 2Y-20.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.26%
Revenue Next 2Y9.96%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BRDS Yearly Revenue VS EstimatesBRDS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 100M 200M 300M
BRDS Yearly EPS VS EstimatesBRDS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -10 -20 -30 -40 -50

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BRDS. In the last year negative earnings were reported.
Also next year BRDS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BRDS Price Earnings VS Forward Price EarningsBRDS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BRDS Per share dataBRDS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

BRDS's earnings are expected to decrease with -20.92% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.92%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BRDS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BIRD GLOBAL INC-CLASS A

NYSE:BRDS (9/22/2023, 8:04:01 PM)

0.9

-0.01 (-1.52%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)08-09 2023-08-09/amc
Earnings (Next)11-13 2023-11-13/amc
Inst Owners1.58%
Inst Owner Change0%
Ins Owners426.5%
Ins Owner Change0%
Market Cap11.64M
Revenue(TTM)220.39M
Net Income(TTM)-99.80M
Analysts43.33
Price Target331.5 (36733.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.41%
Min EPS beat(2)-71.57%
Max EPS beat(2)42.75%
EPS beat(4)2
Avg EPS beat(4)2.98%
Min EPS beat(4)-71.57%
Max EPS beat(4)73.64%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-42.7%
Min Revenue beat(2)-54.36%
Max Revenue beat(2)-31.04%
Revenue beat(4)1
Avg Revenue beat(4)-21.17%
Min Revenue beat(4)-54.36%
Max Revenue beat(4)27.95%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)94.03%
PT rev (3m)94.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-2400%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-8.28
EYN/A
EPS(NY)-6.37
Fwd EYN/A
FCF(TTM)-3.3
FCFYN/A
OCF(TTM)-2.57
OCFYN/A
SpS17.04
BVpS-0.84
TBVpS-3.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.01%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.41%
Cap/Sales 4.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.21
Quick Ratio 0.19
Altman-Z -12.27
F-Score3
WACC9.84%
ROIC/WACCN/A
Cap/Depr(3y)200.34%
Cap/Depr(5y)N/A
Cap/Sales(3y)54.49%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-441.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-108.57%
EPS Next Y-52.06%
EPS Next 2Y-20.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.19%
Revenue growth 3Y17.58%
Revenue growth 5YN/A
Sales Q2Q%-52.68%
Revenue Next Year4.26%
Revenue Next 2Y9.96%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y81.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year112.36%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y57.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.82%
OCF growth 3YN/A
OCF growth 5YN/A

BIRD GLOBAL INC-CLASS A / BRDS FAQ

What is the fundamental rating for BRDS stock?

ChartMill assigns a fundamental rating of 1 / 10 to BRDS.


Can you provide the valuation status for BIRD GLOBAL INC-CLASS A?

ChartMill assigns a valuation rating of 0 / 10 to BIRD GLOBAL INC-CLASS A (BRDS). This can be considered as Overvalued.


How profitable is BIRD GLOBAL INC-CLASS A (BRDS) stock?

BIRD GLOBAL INC-CLASS A (BRDS) has a profitability rating of 0 / 10.


What is the financial health of BIRD GLOBAL INC-CLASS A (BRDS) stock?

The financial health rating of BIRD GLOBAL INC-CLASS A (BRDS) is 0 / 10.